OnKure Therapeutics (NASDAQ:OKUR) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.54) by 158.49 percent. This is a 127.19 percent increase over losses of $(1.14) per share from the same period last year.